AATS: American Association for Thoracic Surgery.
Watch the AATS Leadership Video
 
Predictors of Major Morbidity and Mortality after Esophagectomy for Esophageal Cancer: An STS General Thoracic Surgery Database Risk Adjustment Model
Cameron D. Wright1, Mark S. Allen2, Joshua D. Grab3, John C. Kucharczuk4; 1Massachusetts General Hospital, Boston, MA; 2Mayo Clinic, Rochester, MN; 3Duke Clinical Research Institute, Durham, NC; 4University of Pennsylvania, Philadelphia, PA

 Comment on this Abstract

Objective: The prediction of perioperative risk in esophagectomy for esophageal cancer is unreliable. We sought to create a model adjusted for preoperative risk factors using the STS General Thoracic Database (STS GTDB).
Methods: The STS GTDB was queried for all patients treated with esophagectomy for esophageal cancer for the time period from January 2002 to June 2006. A multivariable risk model for mortality and major morbidity was constructed and confirmed with a bootstrap analysis.
Results: There were 1393 esophagectomies performed by 50 participating centers. Patients older than 75 constituted 17% (293/1393) of the cohort. The hospital mortality was 2.4% (33/1393). Major morbidity (defined as reoperation for bleeding (n=5), anastomotic leak (n=143), pneumonia (n=97), reintubation (n=108), ventilation beyond 48 hours (n=37) or death (n=33)) occurred in 20.6% (287/1393) of patients. The mean length of stay was 14 days for the entire cohort (median 9 days) and 27 days for patients with major morbidity. Induction therapy was administered in 42% (590/1393) of patients and was not associated with increased morbidity or mortality. Preoperative spirometry was obtained in 36% (507/1393) of patients. A FEV1<60% of predicted was associated with major morbidity (OR 1.80, p=0.002). The multivariate predictors of major morbidity are seen in the Table.
Conclusion: Thoracic surgeons participating in the STS GTDB perform esophagectomy with a low mortality. Age, race, medical co-morbidities, smoking status and significant obstructive lung disease are predictors of major morbidity and mortality after esophagectomy for esophageal cancer. Prognostic factors identified in this analysis may help to predict risk in individual patients and guide quality improvement by risk-adjusted feedback.

Predictors of Major Morbidity after Esophagectomy
Variable Odds Ratio 95% CI P Value
Age>75 1.36 1.06-1.74 0.015
Race-Black 2.95 1.67-5.24 <0.001
CHF 2.88 1.40-5.93 0.004
PVD 1.93 1.30-2.90 0.001
Diabetes 1.43 1.03-2.00 0.034
Smoker 1.42 1.08-1.86 0.011
ASA rating 3 or 4 1.45 1.14-1.84 0.002

ASA=American Society of Anesthesiology rating

Back to 88th Annual Meeting
Back to Program Outline
We Model Excellence
Follow AATS on Facebook
Copyright © American Association for Thoracic Surgery. All rights reserved.
Read the Privacy Policy.
IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.